Analysis Of Income And Expense [Abstract]

Redcare Pharmacy N.V. - Filing #5831390

Concept 2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
2,370,575,000 EUR
1,798,758,000 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]
Share of profit (loss) of associates and joint ventures accounted for using equity method
415,000 EUR
226,000 EUR
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
46,154,000 EUR
793,000 EUR
0 EUR
0 EUR
0 EUR
0 EUR
45,027,000 EUR
334,000 EUR
45,361,000 EUR
0 EUR
865,000 EUR
12,633,000 EUR
0 EUR
13,430,000 EUR
0 EUR
0 EUR
12,565,000 EUR
69,000 EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
45,361,000 EUR
12,564,000 EUR
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests
793,000 EUR
69,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.